Study Stopped
few patient feedback and principal investigator disponibility
EssaiClinique_CBSM
CBSM
Interest of Cognitive-behavioral Therapies Based on the CBSM (Cognitive Behavior Stress Management) for the Management of Patients Suffering From Pain Related to Cancer.
2 other identifiers
observational
25
1 country
1
Brief Summary
The CBSM is a program combining cognitive and behavioral therapies, relaxation provided in groups of 8 to 10 patients. This program has demonstrated benefits in stress management skills, adaptive strategies, anxiety, quality of life, social inclusion, medication adherence, depression, therapeutic alliance, and general well-being. It would also improve breast cancer survival after adjuvant therapy. This program has been put in place at the center of pain for patients with cancer pain in any stage. This study aims to evaluate the benefits of this technique on a patient population suffering from chronic pain related to cancer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Sep 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2018
CompletedFirst Submitted
Initial submission to the registry
January 15, 2019
CompletedFirst Posted
Study publicly available on registry
March 20, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2020
CompletedSeptember 2, 2020
August 1, 2020
1.4 years
January 15, 2019
August 31, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Measurement of emotional stress (PSS14)
assessment of the evolution of stress over a period of 3 months: Questionnaire PSS14
evaluation at the beginning of the meeting and at 9 weeks
Secondary Outcomes (6)
Inclusion rate
up to 18 months
Satisfaction
at 6 months
Measurement of quality of life
evaluation at the beginning of the meeting and at 9 weeks and then at 3 months
Pain Disability Index (PDI)
evaluation at the beginning of the meeting and at 9 weeks and then at 3 months
concise questionnaire on pain short version (QCD)
evaluation at the beginning of the meeting and at 9 weeks and then at 3 months
- +1 more secondary outcomes
Study Arms (2)
CBSM
Patients included in this group participate in the CBSM program. They attend 10 sessions of stress management according to the CBSM program, 9 take place over 3 months and the tenth session takes place 3 months after the 9th session. The session is composed of relaxation and cognitive and behavioral therapy, which is carried out in groups of 8 to 10 patients
Waiting list
The CBSM group is compared to the "waiting list" group that does not benefit from the CBSM program. After completing their assessment in the "waiting list" group, patients in this group will be integrated into the CBSM group but will not be evaluated as such.
Interventions
Management of patients in 10 group sessions with cognitive and behavioral therapies associated with relaxation in order to learn how to manage stress
Eligibility Criteria
Patient being treated for cancer, undergoing treatment or having completed treatment, at any stage and suffering from chronic pain
You may qualify if:
- Over 18,
- Currently treated or treated for cancer (solid or otherwise), any stage combined.
- With chronic pain related to cancer or its treatment
- Never benefited from the management of stress by this technique
- Knowing how to read, write and speak French
- Person affiliated with social security or beneficiary of an equivalent plan.
You may not qualify if:
- Life expectancy of less than 6 months
- Patients unable to travel for 10 sessions on the structure
- Person deprived of liberty by judicial or administrative decision, person subject to a legal protection measure.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Grenoble University Hospital
La Tronche, Isère, 30700, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Claudine BERTHOZAT, MD
pain center, Grenoble University Hospital
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 15, 2019
First Posted
March 20, 2019
Study Start
September 1, 2018
Primary Completion
February 1, 2020
Study Completion
February 1, 2020
Last Updated
September 2, 2020
Record last verified: 2020-08